期刊文献+

犀角地黄汤加减治疗真性红细胞增多症验案1则

One Proved Case of Polycythemia Vera Treated with Xijiao Dihuang Decoction Jiajian
下载PDF
导出
摘要 真性红细胞增多症发病率低、症状复杂,在诊治时常遇到“无法可循”的困境,本文以“选取主症,视症为病,探求病因,辨证选方”为思路,选取犀角地黄汤加减治疗,效果显著,印证了中医辨证论治的有效性,也为罕见病、疑难病的中医治疗拓宽了思路和方法。
作者 崔正九 邢建军 刁娟娟 潘月丽 CUI Zhengjiu;XING Jianjun;DIAO Juanjuan;PAN Yueli
出处 《国医论坛》 2023年第2期60-61,共2页 Forum On Traditional Chinese Medicine
基金 山东省中医药科技发展计划项目(2019-0972)。
  • 相关文献

参考文献2

二级参考文献54

  • 1Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasmsand acute leukemia [J]. Blood, 2016, 127 (20):2391-2405. doi: 10.1182/blood-2016-03 -643544.
  • 2Moulard O, Mehta J, Fryzek J, et al. Epidemiology of myelofi- brosis, essential thrombocythemia, and polycythemia vera in the European Union[J]. Eur J Haematol, 2014, 92(4):289-297. doi: 10.1111/ejh.12256.
  • 3Tefferi A, Guglielmelli P, Larson DR, et al. Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis [J]. Blood, 2014, 124(16):2507-2513. doi:10.1182/blood-2014-05- 579136.
  • 4Barbui T, Thiele J, Vannucchi AM, et al. Rethinking the diagnos- tic criteria of polycythemia vera [J]. Leukemia, 2014, 28 (6): 1191-1195. doi: 10.1038/leu.2013.380.
  • 5Silver RT, Chow W, Orazi A, et al. Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis [J]. Blood, 2013, 122 ( 11 ):1881-1886. doi: 10.1182/blood-2013-06- 508416.
  • 6Barbui T, Thiele J, Carobbio A, et al. Masked polycythemia vera diagnosed according to WHO and BCSH classification [J]. Am J Hematol, 2014, 89(2):199-202. doi:10.1002/ajh.23617.
  • 7Lussana F, Carobbio A, Randi ML, et al. A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera [J]. Br J Haematol, 2014, 167(4):541-546. doi: 10.1111/bjh. 13080.
  • 8Barbui T, Thiele J, Carobbio A, et al. Discriminating between essential thrombocythemia and masked polycythemia vera in JAK2 mutated patients [J]. Am J Hematol, 2014, 89 (6):588- 590. doi: 10.1002/ajh.23694.
  • 9Barbui T, Thiele J, Passamonti F, et al. Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome [J]. Blood, 2012, 119:2239-2241. doi: 10.1182/ blood-2011-11393819.
  • 10Thiele J, Kvasnicka HM, Zankovich R, et al. The value of bone marrow histology in differentiating between early stage polycythemia vera and secondary (reactive) polycythemias [J]. Haematologica, 2001, 86(4) :368-374.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部